CSX (CSX) Margin Compression Challenges Bullish Narratives Heading Into Q1 2026 Earnings
CSX (CSX) has just opened its 2026 reporting year with investors still focused on the recent Q4 2025 numbers, where revenue came in at US$3.5b and basic EPS was US$0.39, setting the reference point for how Q1 performance will be judged. Over the past few quarters, revenue has held in a tight band around US$3.4b to US$3.6b, while basic EPS moved between US$0.34 and US$0.44, giving a clear read on how small shifts in volumes and pricing flow through to earnings. With trailing net margins at 20.5% versus 23.9% a year earlier, the latest results put profitability in sharp focus as investors weigh how much earnings power the current network can sustain.
See our full analysis for CSX.With the recent numbers on the table, the next step is to see how this earnings profile lines up with the most common narratives around CSX's growth prospects, risk profile, and long term profitability story.
See what the community is saying about CSX
Margins Ease From 23.9% To 20.5%
- Over the last 12 months, CSX converted US$14.1b of revenue into US$2.9b of net income, giving a 20.5% net margin compared with 23.9% a year earlier.
- Consensus narrative points to future margin support from projects like the Howard Street Tunnel and Blue Ridge rebuild, yet
- the 7% decline in total revenue cited in the narrative sits alongside trailing revenue of US$14.1b and lower net income of US$2.9b versus US$3.5b previously, which keeps recent compression in focus,
- while the same narrative leans on service improvements and new industrial projects to help margins, even as the reported 3% annual EPS decline over five years shows that past profitability has not followed that path yet.
P/E Of 29.7x Versus 40.7x Industry
- CSX trades on a trailing P/E of 29.7x, above the peer average of 27.4x but below the wider US Transportation industry at 40.7x, with the share price at US$46.18.
- Analysts' consensus view links future earnings growth of about 6.9% a year and revenue growth of about 4.2% a year to this multiple, yet
- the current price of US$46.18 sits above the DCF fair value of about US$40.04, which is lower than the analyst price target of US$44.37 referenced in the narrative,
- and the expectation that the P/E moves to 24.4x by 2029 builds on the idea of margin rising toward 25.1%, which contrasts with the recent move from a 23.9% margin to 20.5%.
DCF And Market Price Out Of Sync
- The stock trades at US$46.18 compared with a DCF fair value of about US$40.04, while trailing EPS over the last four quarters totals about US$1.54.
- Bears argue that a 3% annual EPS decline over five years and a margin step down to 20.5% leave limited room for error at this price, and that concern is partly echoed by the data because
- the DCF gap of roughly US$6 per share and the shift from US$3.5b in net income a year ago to US$2.9b now both point to a weaker trailing earnings base than the forward story implies,
- while the consensus price target of US$44.37 sits below the current US$46.18 level, even as forecasts call for earnings to reach US$4.0b and EPS of US$2.33 by around 2029.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for CSX on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Mixed messages from the numbers and narratives so far? Take a closer look at the figures, pressure test the assumptions, and weigh up the 2 key rewards and 2 important warning signs.
See What Else Is Out There
CSX is working with softer margins, a 3% annual EPS decline over five years, and a share price above its DCF fair value and analyst target.
If that mix of compressed profitability and a richer valuation leaves you cautious, it could be worth hunting for companies on the 55 high quality undervalued stocks that pair stronger value signals with more support from recent earnings.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if CSX might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com